HIGHLIGHTS
- who: Juan Garcu00eda-Bernalt Diego and colleagues from the Salamanca-Research Centre for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, Salamanca, Spain have published the research work: The Future of Point-of-Care Nucleic Acid Amplification Diagnostics after COVID-19: Time to Walk the Walk, in the Journal: (JOURNAL)
- what: A study was conducted to evaluate the performance of the OptiGene Ltd SARS-CoV-2 RT-LAMP in 559 raw NP swabs and 86,760 raw saliva samples, as well as RNA extracted from over 12,000 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.